| Income statement (USD) | FY 2025 ended Dec 31, 2025 | FY 2024 ended Dec 31, 2024 | FY 2024 ended Dec 31, 2023 | FY 2024 ended Dec 31, 2022 |
|---|---|---|---|---|
| Revenue | 12.91B | 10.07B | 7.69B | 6.64B |
| Gross profit | 1.52B | 1.27B | 1.14B | 1.08B |
| Selling, general and admin | 1.22B | 1.16B | 1.08B | 925.19M |
| Operating income | 295.25M | 107.95M | 58.13M | 118.86M |
| EBITDA | 459.53M | 312.44M | 260.46M | 322.83M |
| Interest expense | 157.31M | 190.55M | 271.90M | 199.81M |
| Income before tax | 137.94M | -95.32M | -213.77M | -80.95M |
| Income tax | 33.15M | -26.39M | -31.51M | 33.15M |
| Net income | 189.11M | 20.52M | -154.60M | -53.91M |
| EPS | 0.94 | -0.09 | -1.31 | -0.46 |
| EPS (diluted) | 0.87 | -0.09 | -1.31 | -0.46 |
| Diluted shares | 219.77M | 193.00M | 117.87M | 117.84M |
From BrightSpring Health Services, Inc.'s 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read income statement or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.